Vupparapalli Reddy 's most recent trade in Novelix Pharmaceuticals Ltd. was a Acquisition of 800,000 Equity Shares done at an average price of Rs. 10 . Disclosure was reported to the exchange on June 26, 2024 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
Vupparapalli Reddy 's has made SAST transactions in Novelix Pharmaceuticals Ltd. recently where a Acquisition of 560,000 shares done . Disclosure was reported to the exchange on June 1, 2026.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Trimurthi | Vupparapalli Reddy & Other | Promoter | Acquisition | 06 Jul 2026 | 560,000 | 2,855,733 (11.95%) | 1.47% | - | 29 May 2026 29 May 2026 |
SAST (29(2)) | - | Conv. of Warrants | |
| Astal Laboratories | Vupparapalli Chandra Sekhar Reddy & Vupparapalli Pavani | Other | Acquisition | 11 Feb 2026 | 1,750,000 | 2,050,000 (4.86%) | 4.15% | - | 14 Jan 2026 14 Jan 2026 |
SAST (29(2)) | - | Pref. Allotment | |
| Trimurthi | Vupparapalli Chandrasekhar Reddy (Revised) | Promoter | Acquisition | 26 Jun 2024 | 800,000 | 800,000 (8.04%) | 9.88% | 10 | 8,000,000 | 11 Jun 2024 11 Jun 2024 |
Insider Trading | Equity Shares | Preferential Offer |
| Trimurthi | Vupparapalli Chandrasekhar Reddy | Promoter | Acquisition | 12 Jun 2024 | 800,000 | 800,000 (8%) | 9.88% | 10 | 8,000,000 | 11 Jun 2024 11 Jun 2024 |
Insider Trading | Equity Shares | Preferential Offer |